Australian Clinical Labs (ASX:ACL) Dividend Payout Ratio: 3.10 (As of Dec. 2025) — 297% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ACL Australian Clinical Labs Ltd ASX:ACL
56 GF Score
Price A$2.38
GF Value A$3.06
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Australian Clinical Labs Dividend Payout Ratio?

Australian Clinical Labs ASX:ACL -0.83% 56 Dividend Payout Ratio is 3.10 as of Dec. 2025, which is 297% above its 10-year median of 0.78. GuruFocus rates ASX:ACL with a GF Score™ of 56/100 and a GF Value™ of A$3.06 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 55 Medical Diagnostics & Research companies, Australian Clinical Labs ranks worse than 69.09% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Australian Clinical Labs's Dividend Payout Ratio for the months ended in Dec. 2025 was 3.10.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Australian Clinical Labs Ltd is 0.88, which seems too high.

The historical rank and industry rank for Australian Clinical Labs's Dividend Payout Ratio or its related term are showing as below:

ASX:ACL' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.14   Med: 0.78   Max: 2.68
Current: 0.88

During the past 6 years, the highest Dividend Payout Ratio of Australian Clinical Labs was 2.68. The lowest was 0.14. And the median was 0.78.

ASX:ACL's Dividend Payout Ratio is ranked worse than
69.09% of 55 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.49 vs ASX:ACL: 0.88

As of today (2026-08-01), the Dividend Yield % of Australian Clinical Labs is 5.31%.

During the past 6 years, the highest Trailing Annual Dividend Yield of Australian Clinical Labs was 21.72%. The lowest was 2.26%. And the median was 4.39%.

Australian Clinical Labs's Dividends per Share for the months ended in Dec. 2025 was A$0.09.

During the past 12 months, Australian Clinical Labs's average Dividends Per Share Growth Rate was 4.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 1.40% per year.

During the past 6 years, the highest 3-Year average Dividends Per Share Growth Rate of Australian Clinical Labs was 1.40% per year. The lowest was 1.40% per year. And the median was 1.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Australian Clinical Labs (ASX:ACL) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Australian Clinical Labs Dividend Payout Ratio Related Terms

Australian Clinical Labs Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Australian Clinical Labs's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Australian Clinical Labs Dividend Payout Ratio Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividend Payout Ratio
Get a 7-Day Free Trial 0.00 0.14 2.68 0.83 0.73

Australian Clinical Labs Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.84 0.32 1.55 0.31 3.10

ASX:ACL vs TMO, DHR, IDXX: Dividend Payout Ratio Comparison

For the Diagnostics & Research subindustry, Australian Clinical Labs's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australian Clinical Labs Dividend Payout Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Dividend Payout Ratio falls into.


ASX:ACL
56GF Score
Australian Clinical Labs Ltd ASX:ACL
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Australian Clinical Labs Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Australian Clinical Labs's Dividend Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jun. 2025 )/ EPS without NRI (A: Jun. 2025 )
=0.125/ 0.171
=0.73

Australian Clinical Labs's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0.09/ 0.029
=3.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 3.10 mean?
Australian Clinical Labs (ASX:ACL) has a Dividend Payout Ratio of 3.10 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Australian Clinical Labs and its competitors. This is 297% above median its historical median of 0.78. Over the past decade, Australian Clinical Labs' Dividend Payout Ratio has ranged from 0.14 to 2.68. According to the industry distribution chart, Australian Clinical Labs ranks #38 out of 55 companies in the Medical Diagnostics & Research industry, placing it in the top 69.1%.
Is Australian Clinical Labs' Dividend Payout Ratio too high?
Australian Clinical Labs' current Dividend Payout Ratio of 3.10 is 297% above median its 10-year median of 0.78. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 2.68. The Medical Diagnostics & Research industry median Dividend Payout Ratio is 0.49. Australian Clinical Labs' value of 3.10 is 532.7% above this industry median. Based on the distribution chart, Australian Clinical Labs ranks #38 out of 55 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Australian Clinical Labs has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Australian Clinical Labs' Dividend Payout Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Australian Clinical Labs ranks #38 out of 55 companies for Dividend Payout Ratio. This places Australian Clinical Labs in the lower half of its industry. The industry median Dividend Payout Ratio is 0.49. Australian Clinical Labs' value of 3.10 is 532.7% above this benchmark. Historically, Australian Clinical Labs' own Dividend Payout Ratio has ranged from 0.14 to 2.68 over the past decade. While the company's 10-year median is 0.78 vs. the industry median of 0.49, Australian Clinical Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.49, based on 55 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Australian Clinical Labs's current Dividend Payout Ratio of 3.10 is 532.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Australian Clinical Labs and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Australian Clinical Labs's current Dividend Payout Ratio is 3.10, which is 297% above median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Australian Clinical Labs stock overvalued right now?
Based on GuruFocus' analysis, Australian Clinical Labs (ASX:ACL) is currently considered Modestly Undervalued. The stock's GF Value™ is A$3.06, compared to a current price of A$2.38 — trading 22.2% below its estimated fair value. The current Dividend Payout Ratio is 3.10, which is 297% above median its 10-year median of 0.78 and 532.7% above the Medical Diagnostics & Research industry median of 0.49. Australian Clinical Labs' overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Australian Clinical Labs (ASX:ACL), the current Dividend Payout Ratio is 3.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Australian Clinical Labs (ASX:ACL) Overvalued in 2026?

Based on GuruFocus' analysis, Australian Clinical Labs stock appears to be undervalued. The current stock price of A$2.38 is trading 22.2% below its estimated GF Value™ of A$3.06. GuruFocus considers Australian Clinical Labs to be Modestly Undervalued.

Key valuation signals for ASX:ACL:

  • Dividend Payout Ratio: 3.10 (297% above median its 10-year median of 0.78)
  • GF Value™: A$3.06 vs. price of A$2.38 (22.2% below fair value)
  • GF Score™: 56/100 with 5 warning signs
  • Industry Position: 532.7% above the Medical Diagnostics & Research median (#38 of 55)

No single metric tells the full story. See the ASX:ACL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Australian Clinical Labs Business Description

Address 1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well established in the states of Western Australia, South Australia, Victoria, and the Northern Territory.
56GF Score

Get the complete analysis for ASX:ACL

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.38
Price
A$3.06
GF Value